| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 03/13/1997 | WO1996039372A3 Macrophage lipid chemoattractant |
| 03/13/1997 | CA2231326A1 Derivatives of 4- (cycloalkyl) piperidines and of 4- (cycloalkylalkyl) piperidines, their preparation and their therapeutic application |
| 03/13/1997 | CA2230362A1 Optically active phenyl pyrimidine derivative as analgesic agent |
| 03/13/1997 | CA2229036A1 Substituted phosphinic compounds and their use as pharmaceuticals |
| 03/12/1997 | EP0761666A2 Antidepressant 1-arylalkyl-4-(alkoxypyridinyl)- or 4-(alkoxypyrimidinyl)piperazine derivatives |
| 03/12/1997 | EP0761650A1 Thermally stable and storable crystalline modification of N-methyl-N-((1S)-1-phenyl-2-((3S)-3-hydroxypyrrolidin-1-yl)-ethyl)-2,2-diphenyl-acetamide and process for its preparation |
| 03/12/1997 | EP0761204A1 Use of extracts of filamentous, non photosynthetic bacteria and the composition containing them |
| 03/12/1997 | EP0760819A1 Tricyclic dicarbonyl derivatives |
| 03/12/1997 | EP0760818A1 Use of tetrahydropteridine derivatives as no-synthase inhibitors |
| 03/12/1997 | EP0760811A1 Imidazole derivatives as histamine receptor h 3? (ant)agonists |
| 03/12/1997 | EP0760676A1 Materials and methods for treatment of plaquing diseases |
| 03/12/1997 | EP0760665A1 COMPOSITION CONTAINING 5HT IA? and 5HT ID? ANTAGONISTS |
| 03/12/1997 | EP0760664A1 Use of pteridine derivatives as no-synthase inhibitors |
| 03/12/1997 | EP0760661A1 Pharmaceutical compositions comprising an opiate antagonist and calcium salts, their use for the treatment of endorphin-mediated pathologies |
| 03/12/1997 | EP0760656A1 Transdermal delivery of anti-epileptic drugs |
| 03/12/1997 | EP0696289B1 Benzo[f]quinoxalindione derivatives, their preparation and their use in drugs |
| 03/12/1997 | EP0693059B1 Perhydroisoindole derivatives, preparation thereof and pharmaceutical compositions containing same |
| 03/12/1997 | EP0673378B1 New triazolopyrimidones, their preparation and their use |
| 03/12/1997 | EP0665830B1 Tilidin dihydrogen orthophosphate, method of preparing it and pharmaceutical preparations containing it |
| 03/12/1997 | EP0662081B1 Ureido-acetamide derivatives, preparation thereof and drugs containing same |
| 03/12/1997 | EP0627919B1 Application of 2-amino 6-trifluoromethoxy benzothiazole (riluzole) for obtaining a drug useful in the treatment of motor neuron diseases |
| 03/12/1997 | EP0618900B1 Substituted tetrahydroisoquinolines and their use as therapeutic agents |
| 03/12/1997 | EP0599908B1 New ganglioside derivatives |
| 03/12/1997 | EP0592571B1 1,2,4-THIADIAZINO[3,4-b]BENZOTHIAZOLE DERIVATIVES, THEIR PREPARATION, AND DRUGS CONTAINING SAME |
| 03/12/1997 | CN1145075A Antagonist's of endothelin receptors |
| 03/12/1997 | CN1145071A Heterocyclic compounds and their preparation and use |
| 03/12/1997 | CN1144801A Beta-Adrenergic agonists |
| 03/12/1997 | CN1144800A 3-substituted oxindole derivatives as potassium channel modulators |
| 03/11/1997 | US5610308 Process for preparing intermediates for thrombin inhibitors |
| 03/11/1997 | US5610295 4-amino-2-(hetero)aryl-butanamides useful as 5-HT1A -antagonists |
| 03/11/1997 | US5610271 Kappa receptor selective opioid peptides |
| 03/11/1997 | US5610183 Phenylglycine derivatives pharmaceutical compositions containing them and their use in therapy |
| 03/11/1997 | US5610176 Tachykinin (NK1) receptor antagonists |
| 03/11/1997 | US5610161 1-azaspiroalkane derivatives; antidepressants, anxiolytic agents; eating disorders |
| 03/11/1997 | US5610158 Anxiolytic agents, sedatives |
| 03/11/1997 | US5610154 Bicyclic carboxamides |
| 03/11/1997 | US5610153 Benzazepinone derivatives |
| 03/11/1997 | US5610145 Carbamate stereoisomers |
| 03/11/1997 | US5610144 Pyrrolidine and thiazolidine derivatives, their preparation and medicaments containing them |
| 03/11/1997 | US5609884 Controlled release naproxen sodium plus naproxen combination tablet |
| 03/11/1997 | CA2015505C Polyamines and polypeptides useful as antagonists of excitatory amino acid neurotransmitters and/or as blockers of calcium channels |
| 03/06/1997 | WO1997008319A1 Genetic alterations related to familial alzheimer's disease |
| 03/06/1997 | WO1997008249A1 Acid resistant calcium carbonate composition containing an aluminum salt and uses therefor |
| 03/06/1997 | WO1997008196A1 Neurturin and related growth factors |
| 03/06/1997 | WO1997008174A1 Interleukin converting enzyme and apoptosis |
| 03/06/1997 | WO1997008168A1 Pyrrolyl tetrahydroquinoxalin diones, their production and use in the treatment of diseases |
| 03/06/1997 | WO1997008166A1 Piperazino derivatives as neurokinin antagonists |
| 03/06/1997 | WO1997008159A1 1(hetero)aryl-4-(condensed thiazol-2-ylalkyl)-piperazine derivatives, their preparation and their use in the treatment of 5-ht1a-receptor mediated disorders |
| 03/06/1997 | WO1997008155A1 Novel 2,3-dioxo-1,2,3,4-tetrahydro-quinoyxalinyl derivatives |
| 03/06/1997 | WO1997008146A1 Pyridinium derivatives and pharmaceutical compositions containing them |
| 03/06/1997 | WO1997008145A1 Meta-guanidine, urea, thiourea or azacyclic amino benzoic acid derivatives as integrin antagonists |
| 03/06/1997 | WO1997008144A1 Substituted benzylaminopiperidine compounds |
| 03/06/1997 | WO1997007801A1 New applications of 5-ethoxycarbonyl-2,4,6-trimethyl-1,4-dihydropyridine-3-carboxylate of 2-[n-(1,2-benzisothiazolyl-3(2h)one-1,1-dioxide]ethyl |
| 03/06/1997 | WO1997007796A1 Use of boswellic acid and its derivatives for inhibiting normal and increased leucocytic elastase or plasmin activity |
| 03/06/1997 | WO1997007789A1 Regulation of intracellular glucocorticoid concentrations |
| 03/06/1997 | WO1997005285A3 Methods and compositions for identifying morphogen analogs |
| 03/06/1997 | WO1996030049A3 Hapten-carrier conjugates for use in drug-abuse therapy |
| 03/06/1997 | DE19532050A1 Pyrrolyl-tetrahydrochinoxalindione, ihre Herstellung und Verwendung zur Bekämpfung von Krankheiten Pyrrolyl tetrahydrochinoxalindione, their preparation and use for controlling diseases |
| 03/06/1997 | CA2230654A1 Genetic alterations related to familial alzheimer's disease |
| 03/06/1997 | CA2230578A1 Pyridinium derivatives and pharmaceutical compositions containing them |
| 03/06/1997 | CA2230209A1 Meta-guanidine, urea, thiourea or azacyclic amino benzoic acid derivatives as integrin antagonists |
| 03/06/1997 | CA2230094A1 Acid resistant calcium carbonate composition containing an aluminum salt and uses therefor |
| 03/06/1997 | CA2203624A1 New applications of 5-ethoxycarbonyl-2,4,6-trimethyl-1,4-dihydropyridine-3-carboxylate of 2-¬n-(1,2-benzisothiazolyl-3(2h)one-1,1-dioxide¦ethyl |
| 03/05/1997 | EP0760240A1 Novel composition stimulating the cerebral activity and based on alcaloids having an eburnamenine nucleus, and preparation methods |
| 03/05/1997 | EP0759983A1 Dna encoding the beta subunit of a mammalian "maxi-k" potassium channel |
| 03/05/1997 | EP0759978A1 Neurotransmitter transporter |
| 03/05/1997 | EP0759934A1 Neurotensin antagonist peptides |
| 03/05/1997 | EP0759925A1 Adenosine derivatives |
| 03/05/1997 | EP0759923A1 New agonist compounds |
| 03/05/1997 | EP0759922A1 New antagonist compounds |
| 03/05/1997 | EP0759920A1 Derivatives of quinuclidine n-oxide as muscarinic receptor ligands |
| 03/05/1997 | EP0759918A1 Piperazine, piperidine and tetrahydropyridine derivatives of indol-3-ylalkyl as 5-ht1d-alpha agonists |
| 03/05/1997 | EP0759910A1 Acid amide derivatives and process for the preparation thereof |
| 03/05/1997 | EP0759899A1 Nitro compounds and their compositions having anti-inflammatory, analgesic and anti-thrombotic acitivities |
| 03/05/1997 | EP0759772A1 Tri-, tetra-, penta-, and polypeptides and their therapeutic use as an antidepressant agent |
| 03/05/1997 | EP0759771A1 Identification of self and non-self antigens implicated in autoimmune disease |
| 03/05/1997 | EP0759768A1 Vasoactive intestinal polypeptide |
| 03/05/1997 | EP0759744A1 Narcotic containing aerosol formulation |
| 03/05/1997 | EP0591333B1 Azanorbornane derivatives |
| 03/05/1997 | EP0585300B1 Galanin antagonist |
| 03/05/1997 | CN1144529A Heterocyclic compounds, their preparation and use |
| 03/05/1997 | CN1034175C Pyrazolopyrimidines compound |
| 03/05/1997 | CN1034174C Process for preparation of imidazoquinoxalines gamma-amino butyric brain receptor ligands |
| 03/04/1997 | US5608079 Certain fused pyrrolecarboxanilides; a new class of GABA brain receptor ligands |
| 03/04/1997 | US5608069 Treatment of nervous system disorders with gamma-aminobutyric acid |
| 03/04/1997 | US5607999 Homo and copolymers with pigments |
| 03/04/1997 | US5607967 Treatment of alzheimer's disease with 5-(tetradecyloxy)-2-furan carboxylic acid |
| 03/04/1997 | US5607960 Indole derivatives as 5-HT1-like agonists for use in migraine |
| 03/04/1997 | US5607959 Analgesics |
| 03/04/1997 | US5607958 Neurotensin receptor binders |
| 03/04/1997 | US5607957 Containing also indole, benzofuran, benzthiophene or indazole moiety; method for treatment and/or prevention of clinical conditions for which a selective agonist of 5-ht1-like receptors is indicated |
| 03/04/1997 | US5607956 1-heteroazolyl-1-heterocyclyl alkane derivatives and their use and their use as neuroprotective agents |
| 03/04/1997 | US5607949 Vasocontrictors, treating migrain |
| 03/04/1997 | US5607946 Quinolone derivatives as dopamine D4 ligands |
| 03/04/1997 | US5607945 Use as antipsychotics, analgesics and depot pharmaceuticals |
| 03/04/1997 | US5607943 Cardioprotective, cerebroprotective, antiinflammatory agents |
| 03/04/1997 | US5607936 Useful in treatment of respiratory diseases |
| 03/04/1997 | US5607935 Treating stroke and cerebral ischemia |
| 03/04/1997 | US5607933 3-arylcarbonyl-1(C-attached-N-heteryl)-1H-indoles |
| 03/04/1997 | US5607690 Diclofenac, hydroxyethyl-pyrroldine or piperidine |